secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adaptimmune Therapeutics PLC (—)
CIK:        0001621227
Form:       8-K
Filed at:   2025-08-14T23:59:59+00:00
Accession:  0001558370-25-011579
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Adaptimmune receives Nasdaq delisting notice due to low bid price; intends to request hearing
--------------------------------------------------------------------------------

- Nasdaq determined ADAP's closing bid price was $0.10 or less for 10 consecutive trading days as of Aug 12, 2025.
- Company is subject to delisting under Low Priced Stocks Rule unless it requests a hearing; it intends to do so.
- Delisting action stayed pending hearing and any extension granted by Nasdaq Hearings Panel; ADSs continue trading.
- Company previously had until Oct 27, 2025 to regain $1.00 bid compliance; new rule triggers separate delisting process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1621227/000155837025011579/0001558370-25-011579-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1621227/000155837025011579/adap-20250814x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-011579

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer